Nice Insight
LOGIN EMAIL
PASSWORD


| |

Back to index

May 2013

April 2013

March 2013

February 2013

January 2013

December 2012

November 2012

October 2012

September 2012

August 2012

July 2012

June 2012

May 2012

April 2012

March 2012

February 2012

January 2012

December 2011

November 2011

October 2011

September 2011

August 2011

July 2011

June 2011

May 2011

April 2011

March 2011

February 2011

CRO / CMO Industry Trends
NI Company News
NI Published Articles
NI Calendar of Events
NI Media Partners
Contact Us
Pharma Chem Outsourcing 2013
September 16-18 Long Branch, NJ
Contact
Victor Coker
Director of Business Intelligence
+1 212 366 4455






New market-research service hopes to quantify trends
in outsourced CMOs, CROs and related services


That’s Nice LLC (New York), a small full-service agency with offices worldwide, is setting up a proprietary information service that will track industry awareness of providers of contract services, to be called Marcom Tracker and Brand Index. Marcom Tracker will be of value to marketing and business development managers at CMOs and CROs, if only to track the promotional activities of their competitors. Brand Index, meanwhile, is intended to be a measure of who the major players are in specific CMO services globally, such as product formulation, lyophilization, fill & finish or packaging. “This is new,” says Nigel Walker, managing director at That’s Nice, explaining that while there are many directories or compilations of service providers, there is very little available in syndicated market research that tracks the businesses by size, reputation or customer awareness. Bio/pharma manufacturers will be able to identify key organizations by type of service, geography and other criteria.

The Brand Index service will be updated quarterly. The first compilation shows that the leading brandnames among CMOs (alphabetically; the exact ranking is available only to subscribers) include:

• 3M Drug Delivery Systems
• Abbott
• BASF
• Baxter BioPharma Solutions
• Baxter International
• DuPont Pharmaceutical and Biopharma Manufacturing
• Genzyme Pharmaceuticals
• GlaxoSmithKline Pharmaceuticals
• Honeywell Process Solutions
• Roche Custom Biotech

Victor Coker, a project manager at the That’s Nice, notes that a CMO is defined as “companies that provide services that assist in the development and commercial manufacturing of API and excipients.” Thus, Honeywell Process Automation—a process automation supplier primarily—becomes a CMO when it helps set up and run, for example, a batch management system at a client site. In this schema, conventional outsourced manufacturing, which is usually thought of as the totality of the CMO market, becomes only 30% of the companies that That’s Nice will track.

Another finding of the survey is that 85% of companies score less than 40% in overall awareness, meaning that most CMOs and CROs are not well known beyond their existing customer base. “Lower awareness suggests a narrow strategic marketing focus, rather than communication to a broader prospective customer base to ensure sustainability,” says the company.

The research data are compiled by monitoring and tracking promotional and business activity, as well as by compensated panels of industry professionals who will regularly be asked to rate the contract firms they are familiar with. Given the dynamic forces coursing through contract manufacturing these days, with major pharmas divesting specialized services almost weekly, even as new outsourcing providers enter from Asia, there could be meaningful insights to the trends in the industry.
back to top


COMPANY INDEX
Company A-Z
Company by Services
Company by Regions
RESOURCE CENTER
CRO / CMO Industry Trends 2012
NI Company News
Published Articles
NI Calendar of Events
NI Media Partners
CMO Leadership Awards 2012
CRO Leadership Awards 2012
COMPANY
Company Profile
LOG IN
CONTACT US

That's Nice LLC
6 West 20th Street
Second Floor
New York, NY 10011-9270
USA

Telephone
The information in this website is intended for research
purposes and is therefore subject to change. Nice Insight
herein takes no responsibility for information that may be
inaccurate. Data was collected from Nice Insight's
Pharmaceutical and Biotechnology Outsourcing surveys
conducted throughout 2012.
CONNECT  
New York
San Diego
London
Frankfurt
Shanghai